Agilent Technologies (NYSE:A) Upgraded at Bank of America

Agilent Technologies (NYSE:A) was upgraded by stock analysts at Bank of America from a “neutral” rating to a “buy” rating in a research report issued on Thursday,Benzinga reports. The firm presently has a $145.00 price objective on the medical research company’s stock, down from their previous price objective of $150.00. Bank of America‘s target price would indicate a potential upside of 25.20% from the company’s previous close.

A number of other analysts also recently issued reports on the company. Barclays reduced their price objective on Agilent Technologies from $150.00 to $140.00 and set an “overweight” rating on the stock in a research note on Tuesday, April 14th. UBS Group reduced their price target on Agilent Technologies from $180.00 to $165.00 and set a “buy” rating for the company in a research report on Thursday, February 26th. Morgan Stanley reduced their target price on Agilent Technologies from $180.00 to $160.00 and set an “overweight” rating on the stock in a research report on Tuesday, March 3rd. Robert W. Baird boosted their price target on Agilent Technologies from $155.00 to $156.00 and gave the company an “outperform” rating in a research note on Tuesday. Finally, TD Cowen dropped their target price on Agilent Technologies from $170.00 to $157.00 and set a “buy” rating on the stock in a report on Thursday, February 26th. Two investment analysts have rated the stock with a Strong Buy rating, thirteen have assigned a Buy rating and one has issued a Hold rating to the company. According to MarketBeat, the company presently has a consensus rating of “Buy” and an average target price of $161.07.

Agilent Technologies Stock Up 0.6%

Shares of A opened at $115.82 on Thursday. The business’s 50 day moving average is $114.99 and its 200 day moving average is $128.79. The company has a market capitalization of $32.73 billion, a PE ratio of 25.57, a price-to-earnings-growth ratio of 2.42 and a beta of 1.22. Agilent Technologies has a 12-month low of $108.35 and a 12-month high of $160.27. The company has a current ratio of 2.07, a quick ratio of 1.59 and a debt-to-equity ratio of 0.44.

Agilent Technologies (NYSE:A) last issued its earnings results on Wednesday, May 27th. The medical research company reported $1.49 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.41 by $0.08. The company had revenue of $1.84 billion for the quarter, compared to the consensus estimate of $1.80 billion. Agilent Technologies had a return on equity of 24.49% and a net margin of 18.26%.The firm’s quarterly revenue was up 10.0% on a year-over-year basis. During the same quarter last year, the company earned $1.31 EPS. Agilent Technologies has set its FY 2026 guidance at 6.000-6.100 EPS and its Q3 2026 guidance at 1.480-1.500 EPS. Research analysts expect that Agilent Technologies will post 5.95 earnings per share for the current fiscal year.

Institutional Investors Weigh In On Agilent Technologies

Hedge funds have recently modified their holdings of the company. Core Wealth Advisors LLC purchased a new stake in Agilent Technologies in the fourth quarter valued at $26,000. SHP Wealth Management purchased a new stake in Agilent Technologies in the fourth quarter valued at $26,000. Board of the Pension Protection Fund purchased a new stake in Agilent Technologies in the fourth quarter valued at $27,000. Navalign LLC purchased a new stake in Agilent Technologies in the fourth quarter valued at $27,000. Finally, Cedar Mountain Advisors LLC purchased a new stake in Agilent Technologies in the first quarter valued at $27,000.

Key Agilent Technologies News

Here are the key news stories impacting Agilent Technologies this week:

• Positive Sentiment: Agilent beat Q2 expectations with adjusted EPS of $1.49 versus consensus around $1.41 and revenue of $1.83 billion versus the $1.80 billion forecast, showing solid execution and 10% year-over-year sales growth. Agilent Reports Second-Quarter Fiscal Year 2026 Financial Results
• Positive Sentiment: The company raised its full-year 2026 profit outlook, citing strong demand for lab tools and research/diagnostic equipment, which supports the case for higher earnings ahead. Agilent raises 2026 profit forecast on strong demand for lab tools
• Positive Sentiment: Management’s updated FY 2026 guidance of $6.00-$6.10 EPS and $7.4 billion-$7.5 billion revenue came in slightly above Wall Street expectations, reinforcing confidence in continued growth. Agilent Reports Second-Quarter Fiscal Year 2026 Financial Results
• Neutral Sentiment: Analyst coverage remained constructive, with RBC starting coverage at Outperform and Baird lifting its price target, which adds support but is not a direct operating catalyst. Analyst coverage updates
• Negative Sentiment: Agilent’s Q3 EPS guidance of $1.48-$1.50 was only in line with, or slightly below, estimates, which may temper enthusiasm despite the stronger full-year outlook. Agilent Reports Second-Quarter Fiscal Year 2026 Financial Results

About Agilent Technologies

Agilent Technologies is a global provider of scientific instrumentation, consumables, software and services for laboratories across the life sciences, diagnostics and applied chemical markets. The company’s product portfolio includes analytical instruments such as liquid and gas chromatographs, mass spectrometers, spectroscopy systems, and laboratory automation solutions, together with reagents, supplies and informatics tools that support measurement, testing and data analysis workflows. Agilent also offers instrument maintenance, qualification and laboratory services designed to help customers improve productivity and comply with regulatory requirements.

Founded as a corporate spin-off from Hewlett?Packard in 1999, Agilent has evolved through a combination of strategic restructuring and acquisitions to concentrate on life sciences, diagnostics and applied laboratories.